期刊文献+

增强型绿色荧光蛋白逆转录病毒载体的构建和表达 被引量:9

Construction and Expression of Retroviral Vector Encoding Enhanced Green Fluorescent Protein
下载PDF
导出
摘要 逆转录病毒载体被广泛用作对造血细胞进行基因转移的工具 ,转导方法的改进有赖于应用可快速分析并被高效选择的基因标志。为此 ,我们克隆了增强型绿色荧光蛋白 (EGFP)基因 ,并构建可表达EGFP的逆转录病毒载体LGSN ,通过脂质体转染和交互感染方法建立高滴度的逆转录产病毒细胞 ,用以分析对造血细胞标记EGFP基因的可行性。流式细胞术和荧光显微镜检测发现 ,EGFP病毒转录的GP +envAm12细胞和K5 62细胞均可发出稳定的绿色荧光信号 ,阳性率可分别达 97%和 86% ;聚合酶链反应分析显示LGSN转导细胞内有原病毒的整合。上述结果提示 ,作为新一代选择性标志 ,EGFP是适于研究对造血细胞基因转移与表达的报告基因 。 Retroviral vectors are wildly used as vehicles for gene transfer into hematopoietic cells based on its potency for efficient gene delivery and integration of transgene in host genome. The development of better transduction protocols depends on gene markers that allow a rapid detection and effective selection of genetically transduced cells. In this study, the enhanced green fluorescent protein(EGFP), a gene that is optimized for detection and expression in mammalian cells, was firstly amplified and cloned by high-fidelity PCR. The vector LGSN carrying EGFP gene was then constructed and the retroviral producer cell lines that yield high titers of LGSN vector in supernatants were developed by liposome-mediated transfection in combination with cross infection. Both GP+envAm12 murine fibroblasts and K562 leukemic cells transduced with EGFP virus demonstrated a stable green fluorescence signal readily detectable by flow cytometry or fluorescence microscopy in up to 97% and 86% of examined cells, respectively. The integration of LGSN provirus in transduced cells was confirmed by PCR analysis. These results indicate EGFP is a suitable reporter molecule for gene transfer and expression in hematopoietic cells. Therefore, the bright and long-term expression of EGFP in living cells will advance the study of gene therapy in vitro and in vivo, particularly for human applications.
出处 《中国实验血液学杂志》 CAS CSCD 2000年第4期261-265,共5页 Journal of Experimental Hematology
关键词 绿色荧光蛋白 逆转录病毒载体 基因表达 构建 green fluorescent protein retroviral vector gene expression gene transfer reporter gene vector construction
  • 相关文献

参考文献14

  • 1DunbarCE,YoungNS.Genemarkingandgenetherapydirectedatprimaryhematopoieticcells.CurrOpinHematol,1996;3:430-437
  • 2KumeA,HanazonoY,MizukamiH,etal.Hematopoieticstemcellgenetherapy:acurrentoverview.IntJHematol,1999;69:227-233
  • 3ChalfieM,TuY,EuskirchenG,etal.Greenfluorescentproteinasamarkerforgeneexpression.Science,1994;263:802-805
  • 4LimonA,BrionesJ,PuigT,etal.High-titerretroviralvectorscontainingtheenhancedgreenfluorescentproteingeneforefficientexpressioninhematopoieticcells.Blood,1997;90:3316-3321
  • 5FuJX,ChenZX,CenJN,etal.Highefficiencyretrovirus-mediatedgenetransfertoleukemiacells.ChinJCancerRes,1999;11:8-12
  • 6FuJX,WangW,RuanCG,etal.Efficientexpressionofhumanmultidrugresistance1genemediatedbyretroviralvectorcontaininginternalribosomalentrysite.中国实验血液学杂志,1999;7:198-204
  • 7唐佩弦.造血干细胞与基因治疗[J].中国实验血液学杂志,1999,7(1):1-3. 被引量:7
  • 8PersonsDA,AllayJA,AllayER,etal.Retroviral-mediatedtransferofthegreenfluorescentproteingeneintomurinehematopoieticcellsfacilitatesscortingandselectionoftransducedprogenitorsinvitroandidentificationofgeneticallymodifiedcellsinvivo.Blood,1997;90:1777-1786
  • 9刘兵,周生,张双喜,孙建民,杨靖清,于晓媅,毛宁.应用绿色荧光蛋白研究外源基因在造血细胞的表达调控[J].中国生物化学与分子生物学报,1999,15(5):699-703. 被引量:5
  • 10MascarenhasL,StripeckeR,CaseSS,etal.GenedeliverytohumanB-precursoracutelymphoblasticleukemiacells.Blood,1998;92:3537-3545

二级参考文献2

  • 1Cheng L,Nature Biotechnol,1996年,14卷,610页
  • 2Allay J,Blood,1995年,85卷,3342页

共引文献10

同被引文献48

  • 1刘秋英,王一飞.血管生成及其抑制剂在前列腺癌中的研究进展[J].中国病理生理杂志,2004,20(12):2347-2352. 被引量:10
  • 2[1]Hussong JW,Rodgers GM,Shami PJ.Evidence of increased angiogenesis in patients with acute myeloid leukemia.Blood,2000,95:309-313.
  • 3[2]OReilly MS,Boehm T,Shing Y,et al.Endostatin:an endogenous inhibitor of angiogenesis and tumor growth.Cell,1997,88:277-285.
  • 4[4]Keyhani A,Jendiroba DB,Freireich EJ.Angiogenesis and leukemia.Leuk Res,2001,25:639-645.
  • 5[5]Kini AR,Peterson LC,Tallman MS.Angiogenesis in acute promyelocytic leukemia:induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid.Blood,2001,97:3919-3924.
  • 6[6]Rosen L.Antiangiogenic strategies and agents in clinical trials.Oncologist,2000,5(Suppl 1):20-27.
  • 7[7]Iversen PO,Sorensen DR,Benestad HB.Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias.Leukemia,2002,16:376-381.
  • 8[8]Scappaticci FA,Smith R,Pathak A,et al.Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.Mol Ther,2001,3:186-196.
  • 9[9]Eisterer W,Jiang X,Bachelot T,et al.Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia.Mol Ther,2002,5:352-359.
  • 10[10]Lai R,Estey E,Shen Y,et al.Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome.Cancer,2002,94:14-17.

引证文献9

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部